1.
van de Kerkhof P, Reich K, Leonardi C, Blauvelt A, Mehta N, Tsai T, You R, Papanastasiou P, Milutinovic M, Griffiths C. Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment. J of Skin [Internet]. 2018Feb.23 [cited 2022Sep.25];2(S1):S18. Available from: https://jofskin.org/index.php/skin/article/view/297